NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Healthy volunteers: regular treatment of bronchial asthma, where a combination
product containing a corticosteroid and a long-acting beta2-adrenergic
agonist (LABA) is indicated for:
•Twice-daily treatment of asthma in patients aged 4 years and older.
•Maintenance treatment of airflow obstruction and reducing
exacerbations in patients with chronic obstructive pulmonary disease (COPD).
1 total trials
Filter these 1 trials by phase, country, sponsor and more.